Hypertension and cerebral white matter lesions in a prospective cohort study.

White matter lesions are frequently found on cerebral MRI scans of elderly people and are thought to be important in the pathogenesis of dementia. Hyper tension has been associated with the presence of white matter lesions but this has been investigated almost exclusively in cross-sectional studies. We studied prospectively the association of these lesions with the duration and treatment of hypertension. We randomly sampled 1077 subjects aged between 60 and 90 years from two prospective population-based studies. One-half of the study subjects had their blood pressure measured between 1975 and 1978 and the other half between 1990 and 1993. All subjects underwent 1.5 T MRI scanning; white matter lesions in the subcortical and periventricular regions were rated separately. Subjects with hypertension had increased rates of both types of white matter lesion. Duration of hypertension was associated with both periventricular and subcortical white matter lesions. This relationship was influenced strongly by age. For participants with >20 years of hypertension and aged between 60 and 70 years at the time of follow-up, the relative risks for subcortical and periventricular white matter lesions were 24.3 [95% confidence interval (CI) 5.1-114.8] and 15.8 (95% CI 3.4-73.5), respectively, compared with normotensive subjects. Subjects with successfully treated hypertension had only moderately increased rates of subcortical white matter lesions and periventricular white matter lesions (relative risk 3.3, 95% CI 1.3-8.4 and 2.6, 95% CI 1.0-6.8, respectively) compared with normotensive subjects. For poorly controlled hypertensives, these relative risks were 8.4 (95% CI 3.1-22.6) and 5.8 (95% CI 2.1-16.0), respectively. In conclusion, we found a relationship between long-standing hypertension and the presence of white matter lesions. Our findings are consistent with the view that effective treatment may reduce the rates of both types of white matter lesion. Adequate treatment of hypertension may therefore prevent white matter lesions and the associated cognitive decline.

[1]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[2]  A. Hofman,et al.  Raised blood pressure and plasma noradrenaline concentrations in teenagers and young adults selected from an open population. , 1979, British medical journal.

[3]  J. Garcìa,et al.  The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. , 1995, Stroke.

[4]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[5]  A. Hofman,et al.  Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. , 2000, Stroke.

[6]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[7]  C. Broeckhoven,et al.  Dutch hereditary cerebral amyloid angiopathy: Structural lesions and apolipoprotein E genotype , 1997, Annals of neurology.

[8]  E Auffray,et al.  Longitudinal study of blood pressure and white matter hyperintensities , 2001, Neurology.

[9]  A. Hofman,et al.  Cerebral white matter lesions and cognitive function: The Rotterdam scan study , 2000, Annals of neurology.

[10]  O B Paulson,et al.  Cerebral autoregulation. , 1990, Cerebrovascular and brain metabolism reviews.

[11]  K. Matsushita,et al.  Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. , 1994, Hypertension.

[12]  J F Toole,et al.  Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1996, Stroke.

[13]  T. Erkinjuntti,et al.  White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. , 1995, Stroke.

[14]  A. Hofman,et al.  Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.

[15]  A Hofman,et al.  A follow‐up study of blood pressure and cerebral white matter lesions , 1999, Annals of neurology.

[16]  Moody Dm,et al.  Does tortuosity in cerebral arterioles impair down-autoregulation in hypertensives and elderly normotensives? A hypothesis and computer model. , 1991 .

[17]  T. Omae,et al.  Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. , 1988, Stroke.

[18]  F. de Leeuw,et al.  Cognitive correlates of cerebral white matter changes. , 1998, Journal of neural transmission. Supplementum.

[19]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[20]  H. Chabriat,et al.  Patterns of MRI lesions in CADASIL , 1998, Neurology.

[21]  A. Hofman,et al.  Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.

[22]  R. Roos,et al.  Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch type (HCHWA‐D): II ‐ A Review of Histopathological Aspects , 1996, Brain pathology.

[23]  J. De Reuck.  The human periventricular arterial blood supply and the anatomy of cerebral infarctions. , 1971, European neurology.

[24]  C. DeCarli,et al.  Association of midlife blood pressure to late-life cognitive decline and brain morphology , 1998, Neurology.

[25]  Matthijs Oudkerk,et al.  Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. , 2000 .